YOU ARE HERE:
Survey shows less than 25% getting ARVS in many countries, despite growth in international funding
An analysis by Global Fund Observer published this week shows that just under half of the countries eligible to apply to the Global Fund to Fight AIDS, TB and Malaria are providing antiretroviral therapy to less than 25% of those who need it, or still have more than 25,000 in need of treatment despite higher levels of coverage.
The analysis is based on data provided by the Global Fund and the President’s Emergency Plan for AIDS Relief rather than individual country estimates of treatment coverage, together with estimates of numbers in need of treatment from the Kaiser Family Foundation's Global Health Facts website.
The full results are available at the Global Fund Observer website.
Highlights from the data are summarised below.
Enormous numerical need
South Africa (1.24 million); Nigeria (555,000), Zimbabwe (472,000) Tanzania (304,000), Kenya (293,000), Mozambique (280,000), Uganda (235,000), Ethiopia (220,000), Malawi (189,000), Zambia (179,000), China (155,000), Côte d’Ivoire (138,000), Cameroon (134,000).
Very poor coverage
Less than 10%: Sudan, Iran, Pakistan, Ukraine, Nepal, Bangladesh, Tajikistan, Madagascar, Egypt – predominantly countries where injecting drug users make up the majority of people with HIV.
Other notable examples of low coverage
South Africa (28%); China (19%); Indonesia (15%); Nigeria (26%) – low coverage in some of the wealthiest countries on the list.
Making stronger progress
Botswana (81%), Brazil (80%), Namibia (88%), Rwanda (71%), Senegal (58%); Thailand (61%); Zambia (46% - substantially better than any neighbouring country).
The analysis is based on data provided by the Global Fund and the President’s Emergency Plan for AIDS Relief rather than individual country estimates of treatment coverage, together with estimates of numbers in need of treatment from the Kaiser Family Foundation's Global Health Facts website.
The full results are available at the Global Fund Observer website.
Highlights from the data are summarised below.
Enormous numerical need
South Africa (1.24 million); Nigeria (555,000), Zimbabwe (472,000) Tanzania (304,000), Kenya (293,000), Mozambique (280,000), Uganda (235,000), Ethiopia (220,000), Malawi (189,000), Zambia (179,000), China (155,000), Côte d’Ivoire (138,000), Cameroon (134,000).
Very poor coverage
Less than 10%: Sudan, Iran, Pakistan, Ukraine, Nepal, Bangladesh, Tajikistan, Madagascar, Egypt – predominantly countries where injecting drug users make up the majority of people with HIV.
Other notable examples of low coverage
South Africa (28%); China (19%); Indonesia (15%); Nigeria (26%) – low coverage in some of the wealthiest countries on the list.
Making stronger progress
Botswana (81%), Brazil (80%), Namibia (88%), Rwanda (71%), Senegal (58%); Thailand (61%); Zambia (46% - substantially better than any neighbouring country).
aidsmap resources
Africa news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Excellent outcomes from five years of antiretroviral use in Botswana
- HIV treatment safe and effective in South African patients with hepatitis B co-infection, but co-infection frequent
Asia and Pacific news
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Reduced dose atazanavir safe and effective in small Thai study
- Switching to AZT from d4T poses challenges in resource-limited settings